Target intelligence / Profile preview

3-phosphoinositide-dependent protein kinase 1 (PDK1) pleckstrin homology domain (PDK1 PH domain)

Target
PDK1 PH domain
Molecular classification
Enzyme, Pleckstrin homology domain, Kinase (part of)
01

Overview

The 3-phosphoinositide-dependent protein kinase 1 (PDK1) pleckstrin homology (PH) domain is a critical regulatory module located at the C-terminus of the PDK1 enzyme, which is often described as a master kinase due to its role in activating numerous AGC family kinases. This domain specifically binds to phosphatidylinositol (3,4,5)-trisphosphate (PIP3) and phosphatidylinositol (3,4)-bisphosphate (PI(3,4)P2) at the plasma membrane, a process essential for the recruitment and subsequent activation of Akt (protein kinase B) via phosphorylation at Thr308. While the PDK1 kinase domain can activate other substrates like S6K and SGK in the cytosol through the PIF pocket, the PH domain is uniquely required for the membrane-dependent activation of the Akt signaling axis. Consequently, the PDK1 PH domain has emerged as a high-value therapeutic target for allosteric inhibitors designed to selectively disrupt Akt signaling—which is frequently hyperactivated in various cancers—without interfering with other vital PDK1-dependent pathways. Targeting this domain offers a potential advantage over traditional ATP-competitive inhibitors by providing greater pathway selectivity, although therapeutic challenges include managing potential metabolic side effects such as insulin resistance and growth impairment.

Other names
PDPK1 PH domainhPDK1 PH domain3-phosphoinositide-dependent protein kinase 1 PH domainPleckstrin homology domain of PDPK1
02

Mechanism of action

Allosteric inhibition of PDK1 recruitment to the plasma membrane by blocking the interaction between the PH domain and phosphoinositides (PIP3/PI(3,4)P2), thereby preventing the co-localization and activation of Akt (protein kinase B) via Thr308 phosphorylation.

03

Biological functions

Signal transductionCell growthCell survivalProtein phosphorylationMembrane recruitmentProtein dimerizationAutoinhibition
04

Disease associations

CancerDiabetesAngiogenesisInflammation
05

Safety considerations

Insulin resistanceHyperinsulinemiaGrowth retardationEmbryonic lethalitySystemic toxicity due to master kinase inhibition
06

Interacting drugs

2-O-benzyl-myo-inositol 1,3,4,5,6-pentakisphosphate (2-O-Bn-InsP5)

2 more in the full profile.

07

Biomarkers

Phospho-Akt (Thr308)PDK1 expression levelsPhosphatidylinositol (3,4,5)-trisphosphate (PIP3) levels

Beyond the preview

Go deeper on 3-phosphoinositide-dependent protein kinase 1 (PDK1) pleckstrin homology domain (PDK1 PH domain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-phosphoinositide-dependent protein kinase 1 (PDK1) pleckstrin homology domain (PDK1 PH domain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call